Seven Bridges Genomics funds open access to bioinformatics research

Back to Press Releases

Seven Bridges Genomics funds open access to bioinformatics research

CAMBRIDGE, MA — Seven Bridges Genomics today announced a new program to pay the open access publication fees for any publication resulting from research conducted on its platform.Under the new program, called Open, any customer can quickly submit their information to be reimbursed for their open access fees through a simple online form.

We want to do everything possible to accelerate the pace of discovery, said Deniz Kural, Seven Bridges Genomics’ CEO.
Open is the next step of what we started with Rabix — our open-source toolkit for creating, running, and sharing bioinformatics workflows. We want to disseminate knowledge faster, and pairing open access research with fully portable workflows is the best way we know to do it.

For more information about Open, and to submit your fee information, visit

For more information about Rabix, and to try a workflow, visit

About Seven Bridges Genomics Inc.

Seven Bridges Genomics is the cloud-powered platform for population-scale bioinformatics. Researchers use it to carry out investigations by interactively working with data. They also automate analyses on the platform to generate answers reproducibly and at scale. Scientists benefit from its speed and compliance with HIPAA, EU data protection directives and the U.S. Safe Harbor agreement. Seven Bridges is the choice of biotechnology and pharmaceutical companies and national governments. It is the only bioinformatics software company to operate at national scale on both sides of the Atlantic, serving both the US and UK governments.